Survival comparison of stage IIA rectal cancer with or without neoadjuvant therapy: a SEER database analysis with propensity score matching.

Yan, Han; Wang, Peng-Yuan; Wu, Ying-Chao; Liu, Yu-Cun

Yan, Han; Wang, Peng-Yuan; Wu, Ying-Chao; Liu, Yu-Cun.

Afiliación

Yan H; Department of General Surgery, Peking University First Hospital, Beijing, China.
Wang PY; Department of General Surgery, Peking University First Hospital, Beijing, China.
Wu YC; Department of General Surgery, Peking University First Hospital, Beijing, China.
Liu YC; Department of General Surgery, Peking University First Hospital, Beijing, China.

J Gastrointest Oncol ; 13(5): 2293-2305, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36388673

Palabras clave

Stage IIA; Surveillance, Epidemiology, and End Results database (SEER database); neoadjuvant therapy; propensity score matching (PSM); rectal cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: J Gastrointest Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google